4 terminated, 2 active not recruiting, 2 recruiting, 1 completed. 12 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 12 | Terminated 4, Active not recruiting 2, Recruiting 2, Completed 1, Not yet recruiting 1, Unknown 1, Withdrawn 1 |
Follow Rectal Neoplasms: new trials by email Literature Review of Rectal Neoplasms trials Research Report on Rectal Neoplasms
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Neoadjuvant Radiochemotherapy Combined With QL1706 for Low Rectal Cancer SCRT+Capoex+QL706, LCRT+Capoex+QL706 - Rectal Cancer | Early Phase 1 | Not yet recruiting | Changhai Hospital | 60 | 2025-05-20 | 2025-04-17 |
| PET-imaging of Two Vartumabs in Patients With Solid Tumors 89Zr-DFO-N-Suc-F8scFv, 89Zr-DFO-N-Suc-C9scFv, PET/CT scan - Solid Tumor, Colon Carcinoma | Early Phase 1 | Recruiting | Var2 Pharmaceuticals | 32 | 2024-12-10 | 2025-12-29 |
| Active Surveillance and Chemotherapy Before Surgery in Treating Participants With Stage II-III Rectal Cancer Chemotherapy, Patient Observation, Questionnaire Administration - Rectal Adenocarcinoma, Stage II Rectal Cancer AJCC v8 | Early Phase 1 | Recruiting | M.D. Anderson Cancer Center | 120 | 2024-03-13 | 2026-11-17 |
| Alterations of Gut Microbiome, Function, and Its Intervention After Defunctioning Ileostomy MIYAIRI 588 - Ileostomy - Stoma, Rectal Cancer | Early Phase 1 | Unknown | Huashan Hospital | 64 | 2023-01-17 | 2023-03-14 |
| An Investigational Scan (64Cu-Labeled M5A Antibody) in Combination With SOC Chemotherapy and Radiotherapy in Locally Advanced Rectal Cancer Copper Cu 64 Anti-CEA Monoclonal Antibody M5A, Imaging Technique - Locally Advanced Rectal Carcinoma, Stage III Rectal Cancer AJCC v8 | Early Phase 1 | Active not recruiting | City of Hope Medical Center | 14 | 2022-08-31 | 2026-06-08 |
| Adaptive Radiation for Locally Advanced Rectal Adenocarcinoma Capecitabine, Radiation Therapy, FOLFOX regimen - Rectal Adenocarcinoma | Early Phase 1 | Active not recruiting | H. Lee Moffitt Cancer Center and Research Institute | 20 | 2021-12-23 | 2026-04-01 |
| Heated Intra-peritoneal Chemotherapy With Doxorubicin and Cisplatin for Abdominal for Pelvic Tumors in Pediatric Patients Cisplatin, Cytoreductive Surgery, Doxorubicin - Malignant Abdominal Neoplasm, Malignant Pelvic Neoplasm | Early Phase 1 | Terminated | Mayo Clinic | 2 | 2019-11-08 | 2025-02-20 |
| Ferumoxytol-Enhanced MRI in Imaging Lymph Nodes in Patients With Locally Advanced Rectal Cancer Contrast-enhanced Magnetic Resonance Imaging, Ferumoxytol - Locally Advanced Rectal Carcinoma, Stage III Rectal Cancer AJCC v7 | Early Phase 1 | Terminated | OHSU Knight Cancer Institute | 2 | 2018-04-27 | 2021-09-10 |
| Cholecalciferol(25-[OH]-Vitamin D) in Treating Patients With Colorectal Cancer cholecalciferol, biopsy, protein expression analysis - Mucinous Adenocarcinoma of the Colon, Mucinous Adenocarcinoma of the Rectum | Early Phase 1 | Withdrawn | Case Comprehensive Cancer Center | 2012-04-01 | 2014-01-17 | |
| Cetuximab and/or Dasatinib in Patients With Colorectal Cancer and Liver Metastases That Can Be Removed by Surgery cetuximab, dasatinib, therapeutic conventional surgery - Liver Metastases, Mucinous Adenocarcinoma of the Colon | Early Phase 1 | Terminated | National Cancer Institute (NCI) | 9 | 2009-12-01 | 2014-05-23 |
| Tumor Necrosis Factor in Patients Undergoing Surgery for Primary Cancer or Metastatic Cancer colloidal gold-bound tumor necrosis factor, electron microscopy, pharmacological study - Adrenocortical Carcinoma, Breast Cancer | Early Phase 1 | Completed | National Institutes of Health Clinical Center (CC) | 108 | 2006-12-01 | 2012-05-02 |
| Vaccine Therapy in Treating Patients With Stage IIB, Stage III, or Stage IV Colorectal Cancer HER-2-neu, CEA peptides, GM-CSF, Montanide ISA-51 vaccine - Colorectal Cancer | Early Phase 1 | Terminated | Craig L Slingluff, Jr | 11 | 2003-03-24 | 2020-03-30 |
Colonic Neoplasms (7) · Sarcoma (3) · Breast Neoplasms (2) · Colorectal Neoplasms (2) · Ovarian Neoplasms (2) · Pancreatic Neoplasms (2) · Stomach Neoplasms (2) · Adrenocortical Carcinoma (1) · Breast Neoplasms, Male (1) · Carcinoma, Hepatocellular (1) · Carcinoma, Ovarian Epithelial (1) · Carcinoma, Renal Cell (1) · Chondrosarcoma (1) · Desmoplastic Small Round Cell Tumor (1)
Digestive System Diseases (12) · Digestive System Neoplasms (12) · Gastrointestinal Diseases (12) · Intestinal Diseases (12) · Intestinal Neoplasms (12) · Neoplasms by Site (12) · Rectal Diseases (12) · Gastrointestinal Neoplasms (11) · Neoplasms (11) · Colorectal Neoplasms (10) · Colonic Diseases (7) · Endocrine Gland Neoplasms (3) · Endocrine System Diseases (3) · Female Urogenital Diseases (3) · Female Urogenital Diseases and Pregnancy Complications (3)
X-Rays (2) · 1,2-diaminocyclohexaneplatinum II citrate (1) · Biopsy (1) · CYT-6091 (1) · Capecitabine (1) · Cetuximab (1) · Cholecalciferol (1) · Cisplatin (1) · Copper (1) · Cytoreduction Surgical Procedures (1) · Dasatinib (1) · Doxorubicin (1) · Drug Therapy (1) · Enzyme-Linked Immunosorbent Assay (1) · Ferrosoferric Oxide (1)
Case Comprehensive Cancer Center (1) · Changhai Hospital (1) · City of Hope Medical Center (1) · Craig L Slingluff, Jr (1) · H. Lee Moffitt Cancer Center and Research Institute (1) · Huashan Hospital (1) · M.D. Anderson Cancer Center (1) · Mayo Clinic (1) · National Cancer Institute (NCI) (1) · National Institutes of Health Clinical Center (CC) (1) · OHSU Knight Cancer Institute (1) · Var2 Pharmaceuticals (1)
United States (8) · China (1) · Netherlands (1)
Alexander Guimaraes (1) · Charles M. Friel, MD (1) · Emily Chan (1) · George Chang (1) · Gooitzen van Dam, MD, PhD (1) · Jeffrey Y Wong (1) · Jessica M Frakes, MD (1) · Matthew Kalady, MD (1) · Patricio C. Gargollo, M.D. (1) · Seth Felder, MD (1) · Smitha Krishnamurthi, MD (1) · Steven A. Rosenberg, MD, PhD (1)
P30CA033572 (1), P30CA068485 (1)